U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral ...

The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...

Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...

TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

The current health news highlights Abridge raising $250 million to boost AI medical documentation, layoffs involving ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...